Trial
RAVE
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
Also called: Rituximab in ANCA-associated vasculitis, RAVE trial
In short
- 1What it is: a trial in therapies and applications.
- 2How it connects: acts on 1 and is affected by 1 concepts — mostly 2 therapy.
- 3Where it sits: trial on the 15-step immune chain.
What it does
CR 64% rituximab vs 53% cyclophosphamide (non-inferior).
Its connections at a glance
Each dot is a concept directly linked to RAVE. Colours show the kind of concept.
Sources & evidenceloading…
Loading reviewed sources…
Graph ID TR006 · concept status: established. Select any connection above to inspect evidence for that specific link.